American Type Culture Collection
ATCC is a global leader in biological materials management, standards, and research support. With over a century of scientific contributions, ATCC provides a diverse collection of authenticated cell lines, microorganisms, and related data. It supports research in basic science, drug discovery, translational medicine, and public health, fostering scientific collaboration worldwide. The organization is committed to advancing scientific standards, supporting global health initiatives, and providing credible model systems for complex research.
Industries
Nr. of Employees
large (251-1000)
American Type Culture Collection
Patents
Products
Authenticated cell line collections
Curated collections of continuous cell lines, primary cells, engineered lines, and 3‑D tumor organoids provided as authenticated biological materials with provenance and annotation for research and assay use.
Microbial and viral strain libraries and panels
Extensive collections of bacterial, viral, fungal, and protist strains and curated panels for infectious disease research, QC, environmental testing, and assay development, including outbreak-relevant isolates.
Genomic and synthetic nucleic acid reference materials
Authenticated genomic DNA, synthetic nucleic acids, and associated sequence data provided as reference controls for molecular diagnostics, assay validation, and regulatory submissions.
Patient-derived tumor model sets with linked metadata
Next-generation cancer models derived from patient tumor tissue with accompanying anonymized clinical information and complete genetic analysis, produced and distributed to support translational and drug-resistance research.
Zika virus strains and nucleic acid controls
Tissue culture-adapted Zika virus strains, inactivated preparations, and synthetic nucleic acid materials released to support diagnostic and vaccine R&D during the Zika outbreak.
Authenticated cell line collections
Curated collections of continuous cell lines, primary cells, engineered lines, and 3‑D tumor organoids provided as authenticated biological materials with provenance and annotation for research and assay use.
Microbial and viral strain libraries and panels
Extensive collections of bacterial, viral, fungal, and protist strains and curated panels for infectious disease research, QC, environmental testing, and assay development, including outbreak-relevant isolates.
Genomic and synthetic nucleic acid reference materials
Authenticated genomic DNA, synthetic nucleic acids, and associated sequence data provided as reference controls for molecular diagnostics, assay validation, and regulatory submissions.
Patient-derived tumor model sets with linked metadata
Next-generation cancer models derived from patient tumor tissue with accompanying anonymized clinical information and complete genetic analysis, produced and distributed to support translational and drug-resistance research.
Zika virus strains and nucleic acid controls
Tissue culture-adapted Zika virus strains, inactivated preparations, and synthetic nucleic acid materials released to support diagnostic and vaccine R&D during the Zika outbreak.
Services
Molecular authentication (STR profiling), mycoplasma testing, and related quality-control assays for cell lines and primary cells.
cGMP-compliant storage, master/working cell bank production, and commercial biorepository operations for clinical and commercial materials.
Design, engineering, and validation of custom and isogenic cell lines and development of associated research reagents and tools for assay and drug-discovery workflows.
Collaborative development and validation of cell-based and molecular assays, potency and stability testing, and contract testing for biologics and diagnostics.
Manufacture of certified reference materials and participation in standards development and consensus publication to support regulatory and laboratory communities.
Operational management of government-funded biorepository programs, including specimen intake, QC (DNA measurement/normalization), storage, inventory control, and regulated distribution under contract.
Molecular authentication (STR profiling), mycoplasma testing, and related quality-control assays for cell lines and primary cells.
cGMP-compliant storage, master/working cell bank production, and commercial biorepository operations for clinical and commercial materials.
Design, engineering, and validation of custom and isogenic cell lines and development of associated research reagents and tools for assay and drug-discovery workflows.
Collaborative development and validation of cell-based and molecular assays, potency and stability testing, and contract testing for biologics and diagnostics.
Manufacture of certified reference materials and participation in standards development and consensus publication to support regulatory and laboratory communities.
Operational management of government-funded biorepository programs, including specimen intake, QC (DNA measurement/normalization), storage, inventory control, and regulated distribution under contract.
Expertise Areas
- Cell line engineering and isogenic model development
- GMP cell banking and cryopreservation
- Large-scale biorepository operations and specimen logistics
- Cell authentication and STR-based identity testing (including nonhuman markers)
Key Technologies
- Genome editing (CRISPR-based workflows)
- Multiplex STR profiling and authentication assays
- Next-generation sequencing and transcriptomics
- Droplet digital PCR and quantitative nucleic acid assays
News & Updates
ATCC expands federal access to public health solutions through a multi-year contract.
Rebecca Bradford promoted to SVP, and new executives Manoj Menon and Rupali Lach join.
Strategies to improve reproducibility in scientific research.
Techniques for isolating and maintaining stem cells.
Awarded the Distinguished Lifetime Achievement Award for her work in cell line identification.
Her contributions have advanced cell line authentication and reproducibility.
ATCC expands federal access to public health solutions through a multi-year contract.
Rebecca Bradford promoted to SVP, and new executives Manoj Menon and Rupali Lach join.
Strategies to improve reproducibility in scientific research.
Techniques for isolating and maintaining stem cells.
Awarded the Distinguished Lifetime Achievement Award for her work in cell line identification.
Her contributions have advanced cell line authentication and reproducibility.